Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
Gamma Launches With $7M in Seed Funding
02 Nov, 2021
Neurophth Closes RMB 400 Million Series B Financing
– Neurophth Biotechnology Ltd. announced the closing of a RMB 400 million ($61.9 million USD) Series-B financing with a premier syndicate of investors, co-led by Guofang Capital and InnoVision Capital.
– Neurophth is a fully-integrated genetic medicines company developing AAV-delivered gene therapies for the treatment of ocular diseases.
– The company has an extensive portfolio of potentially curative gene therapies for the treatment of ocular genetic diseases.
